USPTO serial 98083169
AVERON
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- DELANEY, ZHALEH SYBIL
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with AVERON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Woonsocket, RI, US
Woonsocket, RI, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Erich G. Rhynhart
ONE CVS DRIVEMAILCODE: 1160WOONSOCKET, RI 02895Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Negotiation of business contracts for others, namely, negotiation of business contracts on behalf of a group or network of pharmaceutical purchasers to purchase pharmaceuticals; business services provided to a group or network of pharmaceutical purchasers, namely, the negotiation and execution of contracts with pharmaceutical drug manufacturers to purchase pharmaceuticals; negotiation of business contracts for others, namely, negotiation of specialty pharmacy member business contracts on behalf of a group or network of pharmaceutical purchasers with pharmaceutical manufacturers and suppliers for discounted pharmaceutical products procured in specialty and retail pharmacies or wholesale; administering discount group purchasing programs for the pharmaceutical industry by negotiating contracts between pharmaceutical drug manufacturers and pharmaceutical purchasers, including retail, specialty, and mail order pharmacies and wholesalers of generic, brand and biosimilar pharmaceuticals, enabling discounts for participant members; negotiation, settlement, and execution of commercial transactions in the nature of contracts on behalf of a group or network of pharmaceutical purchasers, including retail, specialty, and mail order pharmacies and wholesalers of generic, brand and biosimilar pharmaceuticals, to purchase pharmaceuticals from drug manufacturers; administering discount group purchasing programs for the pharmaceutical industry by negotiating contracts with pharmaceutical prescription drug manufacturers and pharmaceutical wholesalers enabling purchasing discounts on specialty pharmacy prescription drugs for specialty and retail pharmacy participant members; business administration and business management all in the field of prescription drug procurement for wholesalers of prescription drugs and specialty and retail pharmacies featuring the same; business records management in the field of prescription drug purchasing and dispensing data for specialty and retail pharmacies; financial records management in the field of prescription drug purchasing data for wholesalers of prescription drugs and specialty and retail pharmacies featuring the same | ACTIVE | — |
| 036 | Financial management in the field of prescription drug procurement for wholesalers of prescription drugs and specialty and retail pharmacies featuring the same | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 9, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 8, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 8, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 8, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 18, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 18, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 18, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 18, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 10, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 10, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 10, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 18, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 18, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 18, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 18, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 16, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 21, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 21, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 17, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 28, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 28, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 28, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 28, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 21, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 13, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 17, 2023 | NWAP | NEW APPLICATION ENTERED | — |